Fusion Progress Report: A Milestone Achieved

If only we could produce fusion power in a controlled way, we would possess a virtually limitless supply of relatively clean and safe energy. Fusion represents the best hope humanity possesses to solve the problems of feeding, housing, and caring for the billions of additional people expected to populate our world in the next century. The problem for fusion researchers has been how to tame this most basic form of energy in the universe. Our sun and all other stars are fueled by fusion reactions

Written byRobert Mccrory
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

In a fusion reaction, nuclei of low atomic weight, such as hydrogen, fuse and thereby form nuclei of higher atomic weight, such as helium. When this occurs, some of the mass of the original nuclei are lost and transformed to energy in the form of high-energy particles. To begin the process, thermonuclear fuel (deuterium and tritium) must be heated to temperatures in excess of tens of millions of degrees centigrade. This heating causes the nuclei to fuse on impact. At such temperatures, it is difficult to contain the fuel long enough to allow efficient thermonuclear burning. Owing to their large masses, stars can contain their high-temperature fusion reactions by tremendous gravitational fields. Unfortunately, that effect cannot be created in the laboratory.

But researchers are getting closer. Progress in the field has come about through two general approaches to confine the fuel and thereby demonstrate controlled fusion reactions: magnetic confinement and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies